Role of epithelial splicing regulatory protein 1 in cancer progression

Mi Jeong Kwon1,2

  • 1Vessel-Organ Interaction Research Center (MRC), College of Pharmacy, Kyungpook National University, Daegu, Republic of Korea. mjkwon94@knu.ac.kr.

Cancer Cell International
|December 19, 2023
PubMed

Insights

Aberrant splicing factors drive cancer. Epithelial splicing regulatory protein 1 (ESRP1) has a dual role in cancer progression, impacting tumor growth and drug response, making it a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Pharmacology

Background:

  • Aberrant alternative splicing, driven by splicing factor dysregulation or mutations, is implicated in cancer initiation and progression.
  • Splicing factors are emerging as critical therapeutic targets for cancer treatment.
  • Epithelial splicing regulatory protein 1 (ESRP1) is an epithelial cell-specific splicing factor involved in alternative splicing of key genes like CD44 and FGFR2.

Purpose of the Study:

  • To review the current understanding of ESRP1's roles and mechanisms in cancer progression.
  • To discuss the emerging novel roles of ESRP1 in cancer, including its impact on tumor metabolism and the tumor microenvironment.
  • To explore recent therapeutic strategies targeting splicing factors, particularly ESRP1, for cancer therapy.

Main Methods:

  • Literature review of studies investigating ESRP1's function in various cancer types.
  • Analysis of research on ESRP1's association with epithelial-mesenchymal transition (EMT) and its downstream targets.
  • Examination of studies exploring ESRP1's influence on tumor cell metabolism, immune cell infiltration, and drug response.

Main Results:

  • ESRP1 exhibits a dual role in cancer progression, acting as a tumor suppressor in some contexts and a promoter in others (e.g., breast and ovarian cancers).
  • ESRP1 downregulation is linked to EMT, while its expression levels correlate with patient prognosis and response to anticancer drugs.
  • Emerging evidence suggests ESRP1 influences tumor growth through regulation of tumor cell metabolism and immune cell infiltration within the tumor microenvironment.

Conclusions:

  • ESRP1 plays a complex and context-dependent role in cancer, extending beyond its known function in EMT.
  • Targeting ESRP1 and other splicing factors presents a promising avenue for novel cancer therapeutic strategies.
  • Further research into ESRP1's multifaceted roles in cancer biology and its interaction with the tumor microenvironment is warranted.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.2K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K